Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole effect on DS-8500a PK in healthy subjects
NCT02790671Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of firuglipel in type 2 diabetes mellitus (T2DM), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: maximum concentration, time of maximum concentration and 1 more. Started May 2016; status: completed.
02
Drugs
firuglipel
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02790671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02790671.